{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-287208","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2022-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.512594+00:00","generated_at":"2026-06-21T16:51:17.695909+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Invivyd issues 6.8M-share warrant to Population Health Partners under $3M consulting deal","bullets":["Cash fee of $500,000/month for 6 months ($3M aggregate) for clinical development advisory services.","Warrant for up to 6,824,712 shares at $3.48/share; vests in tranches tied to market cap milestones up to $1.5B by 2030.","Invivyd board members Clive Meanwell and Tamsin Berry are respectively managing partner and partner of PHP.","PHP to advise on clinical development and regulatory matters for NVD200 and other candidates.","Press release highlights PHP leadership team’s success at The Medicines Company and Pfizer."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-287208","json":"https://secwatch.observer/filing/0001193125-22-287208.json","markdown":"https://secwatch.observer/filing/0001193125-22-287208.md","text":"https://secwatch.observer/filing/0001193125-22-287208.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000119312522287208/0001193125-22-287208-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000119312522287208/d410212d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T16:51:17.695909+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad2cf0c32d6869c46ec84d88e936e2c103fc0288","claim":"Invivyd, Inc. entered into Master Services Agreement with Population Health Partners, L.P. valued at aggregate fee of $3,000,000 (effective 2022-11-15).","evidence_excerpt":"On November 15, 2022 (the “Effective Date”), Invivyd, Inc. (the “Company”) entered into a Master Services Agreement with Population Health Partners, L.P. (“PHP”), pursuant to which PHP agreed to provide services and create deliverables for the Company as agreed between the Company and PHP and set forth in one or more work orders under such agreement (the “MSA”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000119312522287208/0001193125-22-287208-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Population Health Partners, L.P."},{"label":"Value","value":"aggregate fee of $3,000,000"},{"label":"Effective","value":"2022-11-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}